FDA Adverse Event Malfunction Summary report: N

INCEPTA

MDR report key: 3211603 · Received July 8, 2013

Report

Report Number
2124215-2013-10307
Event Type
Malfunction
Date Received
July 8, 2013
Date of Event
May 3, 2013
Report Date
May 3, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AK
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT WITH THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) RECEIVED INAPPROPRIATE THERAPY FOR AN ATRIAL TACHYCARDIA. THE DEVICE DELIVERED SHOCKS UNTIL THERAPY WAS EXHAUSTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONTACTED FOR TECHNICAL ASSISTANCE. THE TS CONSULTANT DISCUSSED PROGRAMMING OPTIONS TO PREVENT INAPPROPRIATE THERAPY DELIVERY. THE ICD REMAINS IMPLANTED AND IN SERVICE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
309386 INCEPTA IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND E162

Patients

Seq Age Sex Outcome Treatment
1 49 YR 4470| 4469| 0292| E162| 1291